Details for Patent: 9,649,280

Which drugs does patent 9,649,280 protect, and when does it expire?

Patent 9,649,280 protects ALKINDI SPRINKLE and is included in one NDA.

This patent has thirty patent family members in twenty-five countries.

Summary for Patent: 9,649,280

Title:	Composition comprising hydrocortisone
Abstract:	The disclosure relates to pharmaceutical compositions useful in the treatment of adrenal insufficiency in paediatric or elderly subjects.
Inventor(s):	Hiep Huatan, Richard Ross, Martin Whitaker, Norbert Poellinger, Annette Grave
Assignee:	Neurocrine Uk Ltd
Application Number:	US14/888,648
Patent Claim Types: see list of patent claims	Use; Composition; Dosage form;

Drugs Protected by US Patent 9,649,280

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Eton	ALKINDI SPRINKLE	hydrocortisone	GRANULE;ORAL	213876-001	Sep 29, 2020		RX	Yes	No			Y			TREATMENT OF ADRENAL INSUFFICIENCY
Eton	ALKINDI SPRINKLE	hydrocortisone	GRANULE;ORAL	213876-002	Sep 29, 2020		RX	Yes	No			Y			TREATMENT OF ADRENAL INSUFFICIENCY
Eton	ALKINDI SPRINKLE	hydrocortisone	GRANULE;ORAL	213876-003	Sep 29, 2020		RX	Yes	No			Y			TREATMENT OF ADRENAL INSUFFICIENCY
Eton	ALKINDI SPRINKLE	hydrocortisone	GRANULE;ORAL	213876-004	Sep 29, 2020		RX	Yes	Yes			Y			TREATMENT OF ADRENAL INSUFFICIENCY

Foreign Priority and PCT Information for Patent: 9,649,280

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	1308933.9	May 17, 2013

PCT Information
PCT Filed	May 12, 2014	PCT Application Number:	PCT/GB2014/051442
PCT Publication Date:	November 20, 2014	PCT Publication Number:	WO2014/184525

International Family Members for US Patent 9,649,280

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2014267041
Brazil	112015028025
Canada	2909060
China	105120848